dc.contributor.author | McGettigan, P | en_US |
dc.contributor.author | Henry, D | en_US |
dc.date.accessioned | 2014-01-28T14:00:34Z | |
dc.date.available | 2011-08-17 | en_US |
dc.date.issued | 2011-09 | en_US |
dc.identifier.issn | 1549-1277 | en_US |
dc.identifier.other | e1001098 | |
dc.identifier.other | e1001098 | |
dc.identifier.other | e1001098 | en_US |
dc.identifier.other | e1001098 | en_US |
dc.identifier.other | e1001098 | en_US |
dc.identifier.other | e1001098 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/5414 | |
dc.description | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.format.extent | ? - ? | en_US |
dc.relation.ispartof | PLOS MED | en_US |
dc.subject | ACUTE MYOCARDIAL-INFARCTION | en_US |
dc.subject | COX-2 INHIBITORS | en_US |
dc.subject | GENERAL-POPULATION | en_US |
dc.subject | METAANALYSIS | en_US |
dc.subject | ROFECOXIB | en_US |
dc.subject | CELECOXIB | en_US |
dc.subject | CYCLOOXYGENASE-2 | en_US |
dc.subject | COMPLICATIONS | en_US |
dc.subject | INDOMETHACIN | en_US |
dc.subject | MELOXICAM | en_US |
dc.title | Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1371/journal.pmed.1001098 | en_US |
pubs.issue | 9 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 8 | en_US |